S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00016419 · COMPLETED

Trial details

NCT number: NCT00016419
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes

Start date: 2001-08-01
Primary completion: 2003-07-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.